FREE Release of CDM-DS v. 3.1

Arturo Grapa agrapa at euclid.ucsd.edu
Sun May 16 20:33:11 EST 1993





                        BITMed ANNOUNCES THE RELEASE
                           OF CDM-DS VERSION 3.1

        The Laboratory for Biological Informatics and Theoretical
Medicine (BITMed) has just announced the FREE release of version 3.1
of the Cellular Device Machine Development System (CDM-DS).
        Equipped with its own object-based Simulation LANGuage SLANG
and advanced methods for evaluating dynamics, the CDM-DS is a tool for
simulating complex systems. Version 3.1 is available for UNIX and
Macintosh platforms.  Current applications include modelling of the
immune and neuroenocrine systems in mice, database mining, HIV disease
progression, and molecular biology.
        The CDM-DS and applications will be presented during the 
following:

        May 14-15       3rd International Cyberspace Conference
                                Austin, TX

        July 6          Nat. Institute of Allergies & Infectious
                        Diseases, Washington D.C.

        July 7-9        International Conference on Intelligent Systems
                        in Molecular Biology
                                Washington D.C.

        Sept. 22-24     Artificial Intelligence, Simulation, and
                        Planning in High Autonomy Systems
                                Tuscon, AR

        Nov. 7-10       International Simtech Conference
                                San Fransisco, CA

        Jan. 1994       Medicine Meets Virtual Reality Conference
                                San Diego, CA

For more information contact:

                Arturo Grapa
                agrapa at ucsd.edu

or:             Prof. Hans B. Sieburg
                hsieburg at ucsd.edu

at:		BITMed
                University of California, San Diego
                9500 Gilman Drive 0603-H
                La Jolla, CA 92093-0603

                PHONE: (619) 543-5081
                FAX:   (619) 543-1235



More information about the Comp-bio mailing list